Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Clinical Study on Safety, Tolerance, Pharmacokinetics and Preliminary Efficacy of MNC-168 Enteric-coated Capsules in Patients With Advanced Malignant Solid Tumors

NCT05383703 is registered in ClinicalTrials.gov with Moon (Guangzhou) Biotechnology Co., Ltd. as lead sponsor.

NCT NCT05383703
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05383703 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Clinical Study on Safety, Tolerance, Pharmacokinetics and Preliminary Efficacy of MNC-168 Enteric-coated Capsules in Patients With Advanced Malignant Solid Tumors
Lead sponsor
Moon (Guangzhou) Biotechnology Co., Ltd.
Phase
Phase 1
Overall status
Completed
Start date
October 28, 2022
Completion date
July 4, 2024
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced malignant solid tumors